Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Method and apparatus for controlling the use of data stored on a media sample
Contactless electrical connector for an induction sensor, and sensor including such a connector
Methods and kits for predicting the responsiveness of hepatocellular carcinoma patients to 5-fluorouracil-based combination chemotherapy
Face recognition through face building from two or more partial face images from the same face
Imaging device
Methods, systems, and computer-readable media for providing an event alert
Computer product, information retrieval method, and information retrieval apparatus
  Randomly Featured Patents
Resolution enhanced optical spectrometer having a fixed number of photodetector elements
Electrode assembly and secondary battery having the same
Charging device having a conductive particle impregnated strand lined contact member
Wall organizer
Portable air pollution capture apparatus with painting tray
Over the door sliding hook
Optical matrix switch with longitudinally configured switch elements
Separating device and cartridge therefor
Force optimization surface apparatus and method